Immunosuppressive Agents: all 5,940 studies that test it
Page 3 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Treatment of Antibody-Mediated Rejection (ABMR) With CarBelRecruitingNCT06918990Phase 1
- Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)RecruitingNCT06913907Phase 4
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesRecruitingNCT06904066Phase 1
- Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCTRecruitingNCT06900777Not applicable
- The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry EyesRecruitingNCT06898853Not applicable
- Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid TreatmentNot yet recruitingNCT06897969Phase 4
- Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity SyndromeRecruitingNCT06895473Phase 2
- COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationNCT06880042Early Phase 1
- Allo HSCT for High Risk HemoglobinopathiesRecruitingNCT06872333Phase 2
- Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT06871410Phase 1
- Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis PatientRecruitingNCT06870500Not applicable
- FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory RhabdomyosarcomaRecruitingNCT06865664Phase 1
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerRecruitingNCT06856200Not applicable
- Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate CancerRecruitingNCT06854250Phase 2
- CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive LeukemiaRecruitingNCT06847269Phase 2
- Sirolimus for Leigh SyndromeEnrolling by invitationNCT06843811Phase 2
- Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHLRecruitingNCT06838832Phase 1/2
- EVR and EPO for Liver Transplant ToleranceRecruitingNCT06832189Phase 1
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamideRecruitingNCT06828796Phase 2
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT06809712Phase 1
- Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT06809699Phase 1
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingNCT06807606Phase 2
- Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)RecruitingNCT06802315Phase 2
- Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin ARecruitingNCT06802055Phase 2
- Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer PatientsNot yet recruitingNCT06795503Phase 3
- Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary DiseaseRecruitingNCT06793475Not applicable
- TRACK-TBI Precision Medicine Part 3 - Option IIEnrolling by invitationNCT06790095Phase 2
- CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic LeukemiaRecruitingNCT06777979Phase 1
- Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)Not yet recruitingNCT06772480Not applicable
- Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaRecruitingNCT06771544Phase 2
- A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseRecruitingNCT06766357Phase 3
- A Study of CAR T-Cells in Relapsed/Refractory Hematologic MalignancyRecruitingNCT06756321Early Phase 1
- Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant RecipientsRecruitingNCT06751992Phase 4
- Effect of Belimumab on Antibody Titers in Primary APS PatientsRecruitingNCT06747312Phase 2
- UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell MalignanciesRecruitingNCT06743503Phase 1
- Systemic Treatment Options for Generalized Lichen PlanusNot yet recruitingNCT06739551Phase 2
- HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCTRecruitingNCT06731504Early Phase 1
- Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS LymphomaRecruitingNCT06730542Phase 1
- Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related ThrombocytopeniaRecruitingNCT06722586Phase 4
- Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)RecruitingNCT06719791Early Phase 1
- A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)RecruitingNCT06716606Phase 3
- Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid CancerNot yet recruitingNCT06713057Phase 2
- Effect and Safety of Benzathine Penicillin Combined With Etanercept on SpondyloarthritisRecruitingNCT06707194Phase 4
- Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving TacrolimusRecruitingNCT06701825Phase 4
- Trial of Cell Based Therapy for DMDRecruitingNCT06692426Phase 1
- A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)Not yet recruitingNCT06682767Phase 1/2
- Different Doses of Sirolimus for the Treatment of Cystic Lymphatic MalformationsRecruitingNCT06673290Phase 2/3
- Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)RecruitingNCT06660420Phase 1
- RESTOR: PK/PD mTORi Inhibition in Older AdultsRecruitingNCT06658093Early Phase 1
- Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine ARecruitingNCT06658002Phase 3
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisRecruitingNCT06654882Phase 3
- Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA TrialRecruitingNCT06653634Phase 4
- Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMFNot yet recruitingNCT06650124Phase 2/3
- MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients With Active Rheumatoid ArthritisRecruitingNCT06649136Phase 4
- Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaRecruitingNCT06647953Phase 3
- High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)Not yet recruitingNCT06646211Phase 2
- CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular CarcinomaNot yet recruitingNCT06641453Phase 1/2
- Intra-Articular Dexmedetomidine: A Treatment for Chronic Knee PainRecruitingNCT06641206Not applicable
- Efficacy of Intramuscular Steroid Injection for Chronic Cough.RecruitingNCT06634823Early Phase 1
- Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal FunctionRecruitingNCT06623630Phase 1
- Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.RecruitingNCT06617182Phase 2
- A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)RecruitingNCT06615050Phase 3
- The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous NephropathyNot yet recruitingNCT06614985Phase 2
- R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaRecruitingNCT06594640Phase 1/2
- Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System InvolvementNot yet recruitingNCT06594432Phase 2
- Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentNot yet recruitingNCT06590090Phase 2
- Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant PatientsRecruitingNCT06584773Phase 4
- A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD ParticipantsRecruitingNCT06576271Phase 1
- Effect of MTX Discontinuation on Shingrix Response in RARecruitingNCT06574594Not applicable
- A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue DiseaseRecruitingNCT06572384Phase 3
- The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular HemorrhageRecruitingNCT06563817Phase 2
- Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular SubtypingNot yet recruitingNCT06561022Phase 2
- A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System LymphomaRecruitingNCT06554561Phase 1/2
- Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) TrialRecruitingNCT06541574Phase 2
- MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) TrialRecruitingNCT06541249Phase 2
- Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine TumorRecruitingNCT06540937Phase 2
- Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaRecruitingNCT06533748Phase 2
- Anti-CD19-CAR-T Cells in Subjects with Relapsed/Refractory B Cell MalignanciesRecruitingNCT06532630Early Phase 1
- Thalidomide for the Symptomatic Large Granular Lymphocytic LeukemiaRecruitingNCT06530576Phase 2
- Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.RecruitingNCT06529536Phase 4
- N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaRecruitingNCT06528496Phase 2
- A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell MalignanciesRecruitingNCT06528301Phase 1
- Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLRecruitingNCT06504459Phase 2
- The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control StudyNot yet recruitingNCT06504420Phase 2
- Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLRecruitingNCT06500273Phase 2
- Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta ThalassemiaRecruitingNCT06490627Phase 2
- Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid CancerRecruitingNCT06482086Phase 2
- Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic DiseasesNot yet recruitingNCT06480630Phase 2
- Belatacept in Heart TransplantationRecruitingNCT06478017Phase 2
- LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT06472479Not applicable
- Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsRecruitingNCT06472388Phase 2
- Precision Administration of Anti-thymocyte Globulin With or Without VerapamilRecruitingNCT06455319Phase 2
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerRecruitingNCT06454383Phase 1
- Phase 2 Study of Fingolimod in Lung CancersRecruitingNCT06424067Phase 2
- MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.RecruitingNCT06412497Phase 2
- Belimumab After Rituximab in Resistant Primary Juvenile SSRecruitingNCT06410833Phase 4
- Sequential Therapies Modeled on Evolutionary Dynamics for Breast CancerRecruitingNCT06409390Phase 2
- Efficacy of Intra-Articular Corticosteroid Injections on Clinical Outcomes in Patients With Operative Distal Radius FracturesNot yet recruitingNCT06407180Not applicable
- Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCDNot yet recruitingNCT06405100Phase 3